Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To report on the use of intravitreal methotrexate (IVT MTX) as part of treatment of presumed tuberculous serpiginous-like choroiditis progressing despite the use of tuberculostatics.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Retina (Philadelphia, Pa.)

Title: Retina (Philadelphia, Pa.)

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1539-2864

ISSN (Print): 0275-004X

Publication date (Electronic): Oct 2013

Volume: 33

Issue: 9

Affiliations

[1 ] *Division of Retina and Inflammation, MIOS, Lausanne, Switzerland; †School of Medicine, Austral University, Buenos Aires, Argentina; ‡Department of Ophthalmology, Medical University of Graz, Graz, Austria; and §Department of Ophthalmology, University of Amsterdam, Amsterdam, The Netherlands.

Article

DOI: 10.1097/IAE.0b013e318285cdbe

PubMed ID: 23584698

SO-VID: f53f57ae-7f91-44f8-ac89-3f35fc0cfebc

History

Data availability:

Comments

Comment on this article

scite_

Cited by 15

See all cited by